IP Library Granted Patent US 11,311,526
Granted Patent B2
US 11,311,526 · App. 16/089,794 · Granted Apr 26, 2022

Radiation mitigator and method of use thereof

Inventors: Milton L. Brown (Brookeville, MD); Yali Kong (Fairfax, VA); Courtney Houchen (Edmond, OK); Sripathi M. Sureban (Oklahoma City, OK); Parthasarathy Chandrakesan (Edmond, OK)
Assignees: Georgetown University; The Board of Regents of the University of Oklahoma
A61K31/454A61K31/4184A61P39/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,311,526
App. No.
16/089,794
Granted
Apr 26, 2022
Kind
B2
Abstract

Provided are methods useful for preventing and mitigating radiation injury, including acute radiation syndrome, comprising administering to a subject a therapeutically effective amount of a compound represented by formula I: or a pharmaceutically acceptable salt thereof, wherein Z is —O— or —N(H)—.

Claims (17)

1. A method for treating or preventing radiation-induced tissue injury, comprising administering to a subject in need thereof a therapeutically effective amount of a compound represented by formula I

or a pharmaceutically acceptable salt thereof, wherein Z is —O— or —N(H)—, thereby treating or preventing radiation-induced tissue injury in the subject.

2. The method of claim 1 , wherein Z is —O—.

3. The method of claim 1 , wherein Z is —N(H)—.

4. The method of claim 1 , wherein the compound is administered prior to exposure of the subject to radiation.

5. The method of claim 1 , wherein the compound is administered after exposure of the subject to radiation.

6. The method of claim 1 , wherein the radiation-induced tissue injury is acute radiation-induced tissue injury.

7. The method of claim 1 , wherein the radiation-induced tissue injury is chronic radiation-induced tissue injury.

8. The method of claim 1 , wherein the tissue comprises gastrointestinal tissue.

9. The method of claim 1 , wherein the tissue comprises hematopoietic tissue.

10. The method of claim 1 , wherein the tissue comprises neural tissue.

11. The method of claim 1 , wherein the compound is administered orally.

12. The method of claim 1 , wherein the compound is administered parenterally.

13. The method of claim 1 , wherein the subject is a mammal.

14. The method of claim 1 , wherein the subject is a human.

15. The method of claim 1 , wherein the radiation-induced tissue injury is prevented.

16. The method of claim 1 , wherein the radiation-induced tissue injury is treated.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 22, 2021
From: HOUCHEN, COURTNEY W.; SUREBAN, SRIPATHI M.; CHANDRAKESAN, PARTHASARATHY
To: THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA
Reel/Frame 056950/0089 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 6, 2018
From: BROWN, MILTON L.; KONG, YALI
To: GEORGETOWN UNIVERSITY
Reel/Frame 047692/0595 →
Continuity (2)
Provisional Application 62316121 · Mar 31, 2016
Related Publication 20200306234A1 · Oct 1, 2020
Cited By (1)
US 12,246,011